Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
529.07
345.04
435.92
517.33
565.16
460.73
598.93
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
529.07
345.04
435.92
517.33
565.16
460.73
598.93
Raw Material Cost
445.82
417.51
385.73
491.03
546.97
546.51
531.17
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
10.13
15.41
19.10
23.48
23.30
26.23
25.20
Selling and Distribution Expenses
36.51
27.42
29.08
43.23
28.55
36.62
33.14
Other Expenses
-0.95
-1.42
-1.86
-2.31
-2.26
-2.55
-2.37
Total Expenditure (Excl Depreciation)
482.97
446.12
415.28
534.68
576.22
583.81
565.78
Operating Profit (PBDIT) excl Other Income
46.1
-101.1
20.6
-17.4
-11.100000000000001
-123.10000000000001
33.199999999999996
Other Income
6.25
7.64
10.71
-0.17
16.14
1.50
2.74
Operating Profit (PBDIT)
51.95
-6.15
119.31
-342.06
99.98
-26.95
130.53
Interest
10.13
15.41
19.10
23.48
23.30
26.23
25.20
Exceptional Items
0.00
0.00
0.00
-0.65
0.00
0.00
0.00
Gross Profit (PBDT)
83.24
-72.47
50.19
26.30
18.19
-85.77
67.77
Depreciation
0.00
87.96
87.96
94.90
94.90
94.63
94.63
Profit Before Tax
41.82
-109.52
12.25
-461.08
-18.22
-147.81
10.70
Tax
0.76
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
40.20
-109.79
7.24
-453.26
-20.22
-148.83
5.24
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
40.20
-109.79
7.24
-453.26
-20.22
-148.83
5.24
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.86
0.27
5.01
-7.82
2.00
1.03
5.46
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
41.07
-109.52
12.25
-461.08
-18.22
-147.81
10.70
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,456.94
1,283.29
1,181.94
938.63
1,391.16
1,411.07
1,560.60
Earnings per share (EPS)
0.06
-0.18
0.01
-0.91
-0.04
-0.3
0.01
Diluted Earnings per share
0.06
-0.18
0.01
-0.91
-0.04
-0.3
0.01
Operating Profit Margin (Excl OI)
8.64%
-29.49%
4.74%
-84.43%
-1.96%
-26.71%
5.54%
Gross Profit Margin
7.91%
-6.25%
22.99%
-70.78%
13.57%
-11.54%
17.59%
PAT Margin
7.6%
-31.82%
1.66%
-87.61%
-3.58%
-32.3%
0.87%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 53.36% vs -20.85% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 137.53% vs -997.54% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 431.16% vs -112.71% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -34.42% vs -19.37% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Shanghai Xuerong Biotechnology Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
529.07
0
529.07
Other Operating Income
0.00
0.00
0.00
Total Operating income
529.07
0
529.07
Raw Material Cost
445.82
0
445.82
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
10.13
0
10.13
Selling and Distribution Expenses
36.51
0
36.51
Other Expenses
-0.95
0.00
-0.95
Total Expenditure (Excl Depreciation)
482.97
0
482.97
Operating Profit (PBDIT) excl Other Income
46.10
0.00
46.10
Other Income
6.25
0
6.25
Operating Profit (PBDIT)
51.95
0
51.95
Interest
10.13
0
10.13
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
83.24
0
83.24
Depreciation
0.00
0
0.00
Profit Before Tax
41.82
0
41.82
Tax
0.76
0
0.76
Provisions and contingencies
0
0
0.00
Profit After Tax
40.20
0
40.20
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
40.20
0
40.20
Share in Profit of Associates
0
0
0.00
Minority Interest
0.86
0
0.86
Other related items
0.00
0.00
0.00
Consolidated Net Profit
41.07
0
41.07
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,456.94
0
1,456.94
Earnings per share (EPS)
0.06
0
0.06
Diluted Earnings per share
0.06
0
0.06
Operating Profit Margin (Excl OI)
8.64%
0%
0.00
8.64%
Gross Profit Margin
7.91%
0%
0.00
7.91%
PAT Margin
7.60%
0%
0.00
7.60%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 52.91 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 53.36% vs -20.85% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -6.39% vs 0.28% in Sep 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.11 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 137.53% vs -997.54% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 325.82% vs 89.67% in Sep 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.57 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 431.16% vs -112.71% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -45.47% vs 243.25% in Sep 2024
Quarterly - Interest
Interest 1.01 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is -34.42% vs -19.37% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -56.65% vs 5.91% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.64%
in Sep 2025Figures in %
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
